Developer docs
API playgroundTry for free, no card

Search company profiles

Ferndale Laboratories, Inc.

Full company profile

uuid004eyxy

Namestring
Ferndale Laboratories, Inc.
Legal namestring
Ferndale Laboratories, Inc.
Company typeenum
Private
Founded yearint
1990
Descriptiontext

Ferndale Laboratories, Inc., operating under the trade name Ferndale Contract Manufacturing, is a privately held contract pharmaceutical manufacturer headquartered in Ferndale, Michigan. The company operates as a subsidiary of Ferndale Pharma Group, a diversified pharmaceutical conglomerate. Ferndale Contract Manufacturing specializes in the production of liquid and semisolid pharmaceutical products, with services spanning the full product lifecycle — from analytical method development, formulation optimization, and clinical trial supply production, through commercial compounding and packaging, to quality assurance, stability testing, validation, regulatory affairs support, artwork design, and warehousing. The company's customer base consists of both large and small pharmaceutical companies requiring FDA-registered manufacturing capacity for liquids and semisolids.

The company's manufacturing operations are housed in an FDA-registered drug production facility compliant with FDA 21 CFR Part 11 standards. A core technical differentiator is its Drug Supply Chain Security Act (DSCSA)-compliant serialization and aggregation capability, built on equipment and software from industry providers including Optel Group, rfXcel, TraceLink, Zebra, Domino, and Cognex. The firm offers dedicated project managers for each client engagement, with contracts typically structured as multi-year project-based engagements. Pricing is custom and quote-based per project, with no publicly disclosed pricing. Average employee tenure exceeds 10 years, providing interdepartmental institutional knowledge that the company positions as a service-quality advantage.

Ferndale Contract Manufacturing operates as a B2B sales-led organization reaching clients primarily through its website (with a contact form), direct phone outreach, and the Ferndale Pharma Group careers platform (Paylocity). The firm is privately held with no public ticker, no disclosed external funding rounds, and no disclosed revenue. The firm publicly references over 30 years of operational longevity in the contract manufacturing space. During the COVID-19 pandemic in April 2020, the company pivoted operations to produce hand sanitizer using the World Health Organization formula, donating over 10,000 units to medical personnel and first responders.

Short descriptiontext

Ferndale Laboratories, Inc. (DBA Ferndale Contract Manufacturing) is a Ferndale, Michigan-based FDA-registered contract pharmaceutical manufacturer specializing in liquid and semisolid drug production, serialization, and packaging for big and small pharma clients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersFerndale, United States
HQ citystring
Ferndale
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contract pharmaceutical manufacturing, liquids and semisolids manufacturing, DSCSA serialization services, FDA-registered drug manufacturing, clinical trial supply production
Industry2 codes
1Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
CodeHLAGABABPrimaryYes
2Clinical Trial Material (CTM) Manufacturing & Supply CDMO
CodeHLAGABAKPrimaryNo
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Contract Pharmaceutical Manufacturing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Pharmaceutical Manufacturing
TypeOne Time License
Description

Provides end-to-end contract manufacturing services for pharmaceutical and related products including development (analytical method development, clinical trial supply, formulation optimization), manufacturing (compounding, packaging), quality assurance/control, and supporting services (regulatory affairs, warehousing). Revenue is generated through project-based manufacturing contracts with pharmaceutical clients.

ferndalelabsmfg.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Custom project-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing is determined per project based on specific client requirements including development scope, manufacturing volume, packaging needs, and regulatory requirements.

ferndalelabsmfg.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Ferndale Laboratories, Inc., doing business as Ferndale Contract Manufacturing, is an FDA-registered contract pharmaceutical manufacturer specializing in liquids and semisolids. The company delivers end-to-end services spanning development (analytical method development and validation, clinical trial supply production, formulation/process optimization, process scale-up, packaging compatibility), manufacturing (compounding and packaging with DSCSA-compliant serialization and aggregation), quality services (assurance, control, stability testing, validation), and supporting services (artwork design, regulatory affairs, warehousing).

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Ferndale Contract Manufacturing is a contract pharmaceutical manufacturing service provider offering a comprehensive suite of services for drug development and production. The company operates a platform of integrated services organized into four main areas: Development Services (analytical method development, clinical trial supply, formulation optimization, scale-up, packaging compatibility), Manufacturing Services (compounding and packaging of liquids and semisolids), Quality Services (assurance, control, stability testing, validation), and Other Services (artwork design, regulatory affairs, warehousing). The company is an FDA-registered drug manufacturer specializing in liquids and semisolids, with over 30 years of operational experience and state-of-the-art serialization capabilities for DSCSA compliance.

Product and service4 records
1Development Services
CategoryPharmaceutical Development Services
Description

Comprehensive pharmaceutical development offerings including analytical method development and validation, clinical trial supply production, formulation and process optimization, process scale-up, and packaging compatibility testing for pharmaceutical companies seeking to bring liquid and semisolid products from formula to market.

2Manufacturing Services
CategoryPharmaceutical Contract Manufacturing
Description

Core contract manufacturing operations providing compounding and packaging services for pharmaceutical liquids and semisolids, with serialization and aggregation capabilities for Drug Supply Chain Security Act (DSCSA) compliance, serving multiple big and small pharma clients.

3Quality Services
CategoryPharmaceutical Quality Services
Description

Quality assurance, quality control, stability testing, and validation services to ensure pharmaceutical products meet regulatory and industry standards throughout the manufacturing lifecycle.

4Other Services
CategoryPharmaceutical Support Services
Description

Supporting services including artwork design, regulatory affairs support, and warehousing that complete the contract manufacturing solution for pharmaceutical clients bringing products to market.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Ferndale Contract Manufacturing is a proud member of the Ferndale Pharma Group, an organizational umbrella providing strategic alignment and operational support across pharmaceutical manufacturing entities.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Pharmaceutical CDMO focused on liquids, creams, ointments, and other semisolid formulations with FDA-inspected facilities. Directly comparable niche focus and customer segment to Ferndale.

TypeBroad incumbent
Description

Pharma services division of Thermo Fisher offering end-to-end CDMO services from development through commercial manufacturing. Competes with Ferndale for pharma contract manufacturing, particularly in liquids and semisolids, but at vastly greater scale and global footprint.

TypeBroad incumbent
Description

Large global pharmaceutical CDMO offering development, manufacturing, and packaging services across multiple dosage forms. Comparable as a contract manufacturer serving pharma clients, but operates at much greater scale and format breadth than Ferndale.

TypeBroad incumbent
Description

European-headquartered pharmaceutical CDMO with broad capabilities including liquids, semisolids, and solids. Direct comparability in liquid/semisolid contract manufacturing with global scale advantages over Ferndale.

TypeDirect peer
Description

Mid-sized CDMO specializing in liquids, semisolids, and oral solid dosage forms for pharmaceutical clients. Closely comparable to Ferndale in size, format specialization, and customer base of small-to-mid pharma companies.

TypeDirect peer
Description

US-based CDMO offering drug product development, manufacturing, and analytical services for liquids and other dosage forms. Similar mid-market positioning and service platform to Ferndale.

TypeDirect peer
Description

CDMO providing formulation development and manufacturing of oral solid doses, liquids, and semisolids. Comparable scale and format overlap with Ferndale, serving similar pharma client base.

TypeDirect peer
Description

API and pharmaceutical services provider offering contract manufacturing, development, and distribution. Overlaps with Ferndale in pharmaceutical contract manufacturing and CDMO services for small-to-mid pharma clients.

TypeEmerging player
Description

Pharmaceutical CDMO within Lubrizol specializing in complex drug products including liquids, semisolids, and sterile formulations. Comparable as a focused contract manufacturer, though with stronger sterile injectable capabilities than Ferndale.

TypeDirect peer
Description

CDMO specializing in formulation development and manufacturing of oral solids, liquids, and semisolids for pharma clients. Highly comparable scope of services and customer profile to Ferndale.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ferndale Laboratories, Inc.

Contract Pharmaceutical Manufacturingferndalelabs.com

Ferndale Laboratories, Inc. (DBA Ferndale Contract Manufacturing) is a Ferndale, Michigan-based FDA-registered contract pharmaceutical manufacturer specializing in liquid and semisolid drug production, serialization, and packaging for big and small pharma clients.

What Ferndale Laboratories, Inc. does

Ferndale Laboratories, Inc., operating under the trade name Ferndale Contract Manufacturing, is a privately held contract pharmaceutical manufacturer headquartered in Ferndale, Michigan. The company operates as a subsidiary of Ferndale Pharma Group, a diversified pharmaceutical conglomerate. Ferndale Contract Manufacturing specializes in the production of liquid and semisolid pharmaceutical products, with services spanning the full product lifecycle — from analytical method development, formulation optimization, and clinical trial supply production, through commercial compounding and packaging, to quality assurance, stability testing, validation, regulatory affairs support, artwork design, and warehousing. The company's customer base consists of both large and small pharmaceutical companies requiring FDA-registered manufacturing capacity for liquids and semisolids.

The company's manufacturing operations are housed in an FDA-registered drug production facility compliant with FDA 21 CFR Part 11 standards. A core technical differentiator is its Drug Supply Chain Security Act (DSCSA)-compliant serialization and aggregation capability, built on equipment and software from industry providers including Optel Group, rfXcel, TraceLink, Zebra, Domino, and Cognex. The firm offers dedicated project managers for each client engagement, with contracts typically structured as multi-year project-based engagements. Pricing is custom and quote-based per project, with no publicly disclosed pricing. Average employee tenure exceeds 10 years, providing interdepartmental institutional knowledge that the company positions as a service-quality advantage.

Ferndale Contract Manufacturing operates as a B2B sales-led organization reaching clients primarily through its website (with a contact form), direct phone outreach, and the Ferndale Pharma Group careers platform (Paylocity). The firm is privately held with no public ticker, no disclosed external funding rounds, and no disclosed revenue. The firm publicly references over 30 years of operational longevity in the contract manufacturing space. During the COVID-19 pandemic in April 2020, the company pivoted operations to produce hand sanitizer using the World Health Organization formula, donating over 10,000 units to medical personnel and first responders.

Ferndale Laboratories, Inc. firmographics

Firmographics
Name
Ferndale Laboratories, Inc.
Legal name
Ferndale Laboratories, Inc.
Website
https://ferndalelabs.com
Company type
Private
Founded year
1990
Operating status
Operating
Headcount range
101–250 employees
Short description
Ferndale Laboratories, Inc. (DBA Ferndale Contract Manufacturing) is a Ferndale, Michigan-based FDA-registered contract pharmaceutical manufacturer specializing in liquid and semisolid drug production, serialization, and packaging for big and small pharma clients.
Ownership category
akta.pro rank

Ferndale Laboratories, Inc. industry classification

Industry
Product category
Contract Pharmaceutical Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro primary industry
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)
akta.pro secondary industry
Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)

Keywords

  • Contract pharmaceutical manufacturing
  • Liquids and semisolids manufacturing
  • DSCSA serialization services
  • FDA-registered drug manufacturing
  • Clinical trial supply production

Where Ferndale Laboratories, Inc. is headquartered

Location

Headquarters

HQ city
Ferndale
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Ferndale Laboratories, Inc. business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Contract Pharmaceutical Manufacturing: Provides end-to-end contract manufacturing services for pharmaceutical and related products including development (analytical method development, clinical trial supply, formulation optimization), manufacturing (compounding, packaging), quality assurance/control, and supporting services (regulatory affairs, warehousing). Revenue is generated through project-based manufacturing contracts with pharmaceutical clients.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom project-based pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Ferndale Laboratories, Inc. product offering

Product offering

Core offering

Ferndale Laboratories, Inc., doing business as Ferndale Contract Manufacturing, is an FDA-registered contract pharmaceutical manufacturer specializing in liquids and semisolids. The company delivers end-to-end services spanning development (analytical method development and validation, clinical trial supply production, formulation/process optimization, process scale-up, packaging compatibility), manufacturing (compounding and packaging with DSCSA-compliant serialization and aggregation), quality services (assurance, control, stability testing, validation), and supporting services (artwork design, regulatory affairs, warehousing).

Product overview

Ferndale Contract Manufacturing is a contract pharmaceutical manufacturing service provider offering a comprehensive suite of services for drug development and production. The company operates a platform of integrated services organized into four main areas: Development Services (analytical method development, clinical trial supply, formulation optimization, scale-up, packaging compatibility), Manufacturing Services (compounding and packaging of liquids and semisolids), Quality Services (assurance, control, stability testing, validation), and Other Services (artwork design, regulatory affairs, warehousing). The company is an FDA-registered drug manufacturer specializing in liquids and semisolids, with over 30 years of operational experience and state-of-the-art serialization capabilities for DSCSA compliance.

Differentiator

Problem solved

Functional benefit

Products and services

  • Development Services Comprehensive pharmaceutical development offerings including analytical method development and validation, clinical trial supply production, formulation and process optimization, process scale-up, and packaging compatibility testing for pharmaceutical companies seeking to bring liquid and semisolid products from formula to market.
  • Manufacturing Services Core contract manufacturing operations providing compounding and packaging services for pharmaceutical liquids and semisolids, with serialization and aggregation capabilities for Drug Supply Chain Security Act (DSCSA) compliance, serving multiple big and small pharma clients.
  • Quality Services Quality assurance, quality control, stability testing, and validation services to ensure pharmaceutical products meet regulatory and industry standards throughout the manufacturing lifecycle.
  • Other Services Supporting services including artwork design, regulatory affairs support, and warehousing that complete the contract manufacturing solution for pharmaceutical clients bringing products to market.

Companies that use Ferndale Laboratories, Inc.

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Ferndale Laboratories, Inc. technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Ferndale Laboratories, Inc. partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Ferndale Pharma GroupcoreStrategic or Co-development PartnerFerndale Contract Manufacturing is a proud member of the Ferndale Pharma Group, an organizational umbrella providing strategic alignment and operational support across pharmaceutical manufacturing entities.

Scale indicators3 records

Recent moves4 records

Expansion highlights3 records

Ferndale Laboratories, Inc. competitors and assessment

Company assessment

Direct peers

  • Halo Pharmaceutical: Pharmaceutical CDMO focused on liquids, creams, ointments, and other semisolid formulations with FDA-inspected facilities. Directly comparable niche focus and customer segment to Ferndale.
  • CoreRx Pharmaceuticals: Mid-sized CDMO specializing in liquids, semisolids, and oral solid dosage forms for pharmaceutical clients. Closely comparable to Ferndale in size, format specialization, and customer base of small-to-mid pharma companies.
  • Alcami Corporation: US-based CDMO offering drug product development, manufacturing, and analytical services for liquids and other dosage forms. Similar mid-market positioning and service platform to Ferndale.
  • Recro Gainesville: CDMO providing formulation development and manufacturing of oral solid doses, liquids, and semisolids. Comparable scale and format overlap with Ferndale, serving similar pharma client base.
  • LGM Pharma: API and pharmaceutical services provider offering contract manufacturing, development, and distribution. Overlaps with Ferndale in pharmaceutical contract manufacturing and CDMO services for small-to-mid pharma clients.
  • Pharmaceutics International (PII): CDMO specializing in formulation development and manufacturing of oral solids, liquids, and semisolids for pharma clients. Highly comparable scope of services and customer profile to Ferndale.

Broad incumbents

  • Thermo Fisher Scientific (Patheon): Pharma services division of Thermo Fisher offering end-to-end CDMO services from development through commercial manufacturing. Competes with Ferndale for pharma contract manufacturing, particularly in liquids and semisolids, but at vastly greater scale and global footprint.
  • Catalent: Large global pharmaceutical CDMO offering development, manufacturing, and packaging services across multiple dosage forms. Comparable as a contract manufacturer serving pharma clients, but operates at much greater scale and format breadth than Ferndale.
  • Aenova Group: European-headquartered pharmaceutical CDMO with broad capabilities including liquids, semisolids, and solids. Direct comparability in liquid/semisolid contract manufacturing with global scale advantages over Ferndale.

Emerging players

  • Particle Sciences (Lubrizol): Pharmaceutical CDMO within Lubrizol specializing in complex drug products including liquids, semisolids, and sterile formulations. Comparable as a focused contract manufacturer, though with stronger sterile injectable capabilities than Ferndale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Ferndale Laboratories, Inc. social profiles

Digital presence

Ferndale Laboratories, Inc. compliance and trust

Trust signal

Compliance1 record

Ferndale Laboratories, Inc. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ferndale Laboratories, Inc. leadership team

Management profile

Number of profiles

Ferndale Laboratories, Inc. funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ferndale Laboratories, Inc. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ferndale Laboratories, Inc.

What does Ferndale Laboratories, Inc. do?

Ferndale Laboratories, Inc., doing business as Ferndale Contract Manufacturing, is an FDA-registered contract pharmaceutical manufacturer specializing in liquids and semisolids. The company delivers end-to-end services spanning development (analytical method development and validation, clinical trial supply production, formulation/process optimization, process scale-up, packaging compatibility), manufacturing (compounding and packaging with DSCSA-compliant serialization and aggregation), quality services (assurance, control, stability testing, validation), and supporting services (artwork design, regulatory affairs, warehousing).

Is Ferndale Laboratories, Inc. a public or private company?

Ferndale Laboratories, Inc. is a private company. It is classified as corporate owned and is currently operating.

When was Ferndale Laboratories, Inc. founded?

Ferndale Laboratories, Inc. was founded in 1990. It employs 101 to 250 people.

Where is Ferndale Laboratories, Inc. based?

Ferndale Laboratories, Inc. is headquartered in Ferndale, United States, in the North America region.

How does Ferndale Laboratories, Inc. make money?

One revenue line is on record: contract Pharmaceutical Manufacturing.

Who are Ferndale Laboratories, Inc.'s main competitors?

Direct peers on record are Halo Pharmaceutical, CoreRx Pharmaceuticals, Alcami Corporation, Recro Gainesville, LGM Pharma and Pharmaceutics International (PII). Broad incumbents are Thermo Fisher Scientific (Patheon), Catalent and Aenova Group. Particle Sciences (Lubrizol) is listed as an emerging player.

Does Ferndale Laboratories, Inc. have an API?

No public API is recorded for Ferndale Laboratories, Inc..

What industry is Ferndale Laboratories, Inc. in?

Ferndale Laboratories, Inc.'s product category is Contract Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO, with a secondary code of HLAGABAK, Clinical Trial Material (CTM) Manufacturing & Supply CDMO. Its NAICS code is 325412 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals